Coming soon
CarveIntel
Pharmaceutical patent intelligence. ABFTO.
Status. Approximately 14 reports. First ABFTO report printing in a few weeks.
What it does. ABFTO: All But FTO. Queries eight patent databases for molecule and patent analysis, and formats the research so a lawyer can review, validate, and sign the freedom-to-operate opinion. The lawyer signs. CarveIntel does not practice law.
Why it matters. FTO work is slow and expensive. CarveIntel compresses research and formatting from days or weeks to minutes, leaving legal judgment with the attorney.
Problems solved. Multi-source patent research, deterministic claim analysis via regex, formatted output for legal review.
Competitors. Solve Intelligence, Clarivate, traditional patent search. Difference: the ABFTO boundary.
Availability. Approximately 14 reports. First printed ABFTO report in a few weeks.